Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JonCohen
    Junior Member
    • Apr 2012
    • 1

    #1

    Hello from NVIDIA

    Hi,

    I'm the manager of the CUDA Libraries and Algorithms group at NVIDIA - that includes all of the libraries that come with CUDA like cuBLAS, cuSPARSE, etc. We also have new initiatives that I would call more "applied research" to develop functionality built on top of CUDA in emerging high-tech areas.

    One of our new focus areas is in bioinformatics. We've been doing some work prototyping short-read aligners in CUDA, similar to BarraCUDA or CUSHAW. We have CUDA-accelerated versions of the BWA and Bowtie2 algorithms, and we are seeing some really nice speedups on our preliminary benchmarking. It's probably not worth saying too much more since none of this has been peer-reviewed yet.

    Based on these success, we are committed to investing more seriously in building bioinformatics expertise at NVIDIA, and making CUDA a platform that is friendly to bioinformatics researchers. Hence, my interest in learning more about bioinformatics.

    I'm happy to answer any questions about CUDA - I see that it comes up from time to time. I don't want to be here as any type of salesman - I will try to be as candid as possible about the strengths and weaknesses of our technology.

    Regards,
    Jon
  • adaptivegenome
    Super Moderator
    • Nov 2009
    • 436

    #2
    Welcome to SEQanswers!

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      Yesterday, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 02:55 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Working...